Awareness of the Egyptian public about COVID-19: what we do and do not know

被引:3
|
作者
Sabry, Nirmeen [1 ]
ElHadidi, Seif [2 ]
Kamel, Ahmed [1 ]
Abbassi, Maggie [1 ]
Farid, Samar [1 ]
机构
[1] Cairo Univ, Fac Pharm, Cairo, Egypt
[2] Future Univ Egypt, Fac Pharmaceut Sci & Pharmaceut Ind, New Cairo, Egypt
来源
INFORMATICS FOR HEALTH & SOCIAL CARE | 2021年 / 46卷 / 03期
关键词
COVID; coronavirus; preventive measures; knowledge; practice; infection control; LMIC;
D O I
10.1080/17538157.2021.1883029
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
To survey the health-seeking behaviors and perspectives of the Egyptian population toward the COVID-19 pandemic. A descriptive survey was designed and disseminated via social media platforms. The survey consisted of 32 questions addressing respondent's demographics, knowledge, practice, and attitude toward the COVID-19 pandemic. A total of 25,994 Egyptians participated in the survey from the 29 Egyptian governorates. More than 99% of the respondents were aware of the COVID-19 pandemic. Responses showed split opinions regarding whether people should wear gloves or masks to prevent COVID-19 infection (47.7% and 49.5% replied with "False", respectively). Almost one-quarter (23.1%) of the respondents went to crowded places during the last 14 days. Calling the emergency hotline and self-isolation at home were the most frequent practices to deal with COVID-19 symptoms (34.1% and 44.5%, respectively). A total of 85% of respondents reported their confidence in the Egyptian healthcare system to win the battle against COVID-19 despite the challenges. A vast majority of this large population sample reported reasonable knowledge levels and potentially appropriate practices toward COVID-19.
引用
收藏
页码:244 / 255
页数:12
相关论文
共 50 条
  • [21] COVID-19 and Dialysis Units: What Do We Know Now and What Should We Do?
    Ikizler, T. Alp
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 76 (01) : 1 - 3
  • [22] Editorial: What do we know about COVID-19 implications for cardiovascular disease?
    Wang, Zeyuan
    Tang, Muyun
    Luan, Xiaodong
    Tevaearai Stahel, Hendrik
    Aikawa, Masanori
    Xie, Mingxing
    Ge, Shuping
    Zhang, Shuyang
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [23] Covid-19: What do we know about the delta omicron recombinant variant?
    Mahase, Elisabeth
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2022, 376 : o792
  • [24] What do we know about the origin of COVID-19 three years later?
    Gaviria, A. Zapatero
    Martin, R. Barba
    [J]. REVISTA CLINICA ESPANOLA, 2023, 223 (04): : 240 - 243
  • [25] CARDIAC TROPONINS AND COVID-19: WHAT DO WE KNOW ABOUT HETEROPHILIC ANTIBODIES?
    Campana, Pasquale
    Forzano, Imma
    Pepe, Marco
    Basile, Christian
    Perillo, Errico Federico
    Ranieri, Alessandro
    Conte, Maddalena
    Parisi, Valentina
    Sibilio, Gerolamo
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24
  • [26] What Do We Really Know About Pulmonary Thrombosis in COVID-19 Infection?
    Raptis, Constantine A.
    Hammer, Mark M.
    Henry, Travis S.
    Hope, Michael D.
    Schiebler, Mark L.
    van Beek, Edwin J. R.
    [J]. JOURNAL OF THORACIC IMAGING, 2020, 35 (06) : 341 - 343
  • [27] Covid-19: What do we know about the late stage vaccine candidates?
    Mahase, Elisabeth
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2020, 371 : m4576
  • [28] Cancer and COVID-19: what do we really know?
    Poortmans, Philip M.
    Guarneri, Valentina
    Cardoso, Maria-Joao
    [J]. LANCET, 2020, 395 (10241): : 1884 - 1885
  • [29] Asthma and COVID-19: What do we know now
    Hughes-Visentin, Alexzandra
    Paul, Anthea B. Mahesan
    [J]. CLINICAL MEDICINE INSIGHTS-CIRCULATORY RESPIRATORY AND PULMONARY MEDICINE, 2020, 14
  • [30] COVID-19 and lung cancer: What do we know?
    Serrano, G.
    Rogado, J.
    Pangua, C.
    Obispo, B.
    Martin Marino, A.
    Perez-Perez, M.
    Lopez-Alfonso, A.
    Lara, M. A.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S1026 - S1026